Price rises have been a key feature of February’s buying: nearly all product groups experienced price rises, including two packs each of pilocarpine eye drops, pregabalin and valsartan caps, and risedronate sodium tabs. Candesartan tabs had two packs among the risers but also had one pack in the fallers.
As usual dispensing doctors retain their pole position in achieving better deals on generics. However, when it comes to parallel imports, the picture is more mixed: dispensing practices and community pharmacies take it in turn to get good deals. Overall, the deals and prices are similar for dispensing doctors and pharmacies, but buying and dispensing patterns disrupt what should be two parallel lines.
DDA members can view the full spreadsheet and exclusive analysis for the DDA by visiting our library of monthly purchase price analyses.